Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A non-metastasizing tumor that arises from the adenohypophysial cells of the anterior lobe of the pituitary gland. The tumor can be hormonally functioning or not. The diagnosis can be based on imaging studies and/or radioimmunoassays. Due to its location in the sella turcica, expansion of the tumor mass can impinge on the optic chiasm or involve the temporal lobe, third ventricle and posterior fossa A frequently associated physical finding is bitemporal hemianopsia which may progress to further visual loss.
39 clinical trials registered, 20 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and medical devices. Pipeline includes 5 PHASE4, 1 PHASE3, 1 PHASE2. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04081701](https://clinicaltrials.gov/study/NCT04081701) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:06 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. |
PHASE4 |
Weill Medical College of Cornell University |
RECRUITING |
[NCT00461188](https://clinicaltrials.gov/study/NCT00461188) | Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA | — | Barts & The London NHS Trust | RECRUITING |
[NCT06523582](https://clinicaltrials.gov/study/NCT06523582) | Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients | — | Universidad Nacional Autonoma de Mexico | RECRUITING |
[NCT06584123](https://clinicaltrials.gov/study/NCT06584123) | Molecular Pituitary Imaging Using 18F-FET PET | NA | University of Cambridge | RECRUITING |
[NCT06949891](https://clinicaltrials.gov/study/NCT06949891) | KETOgenic Diet Therapy in Patients With ACROmegaly | NA | Erasmus Medical Center | RECRUITING |
5 publications have been identified in PubMed for pituitary gland adenoma. Research spans Case Report / Case Series (60%), Clinical Trial Publication (20%), and Epidemiology / Natural History (20%).
Pala A (2025). [PMID: 40805263](https://pubmed.ncbi.nlm.nih.gov/40805263/). *Cancers*. [Epidemiology / Natural History]
Kanley AM (2025). [PMID: 39678651](https://pubmed.ncbi.nlm.nih.gov/39678651/). *JCEM case reports*. [Case Report / Case Series]
Li X (2024). [PMID: 38883224](https://pubmed.ncbi.nlm.nih.gov/38883224/). *Clinical case reports*. [Case Report / Case Series]
Zheng Z (2024). [PMID: 39735648](https://pubmed.ncbi.nlm.nih.gov/39735648/). *Front Endocrinol (Lausanne)*. [Clinical Trial Publication]
Sqalli Houssaini A (2024). [PMID: 39328951](https://pubmed.ncbi.nlm.nih.gov/39328951/). *Radiol Case Rep*. [Case Report / Case Series]